Falling Walls Circle Tables will give the spotlight to world-leading scientists, science strategists and policy-makers from academia, business and politics discuss how we can apply science, research and innovation to get the world moving again.

Vaccinations provide a pathway to recovery from the COVID-19 pandemic, but they also present immense challenges.  In this Falling Walls Circle Table – held before phase 3 trial data from any COVID-19 vaccine research had been published – the panel discussed how companies have raced to develop vaccines, and to produce them at vast scales.

The doctrine has long been that it takes a minimum of two years to develop medications for a new pathogen. Accelerating this development has presented great challenges to supply chains, which have had to ramp up operations, while continuing to produce their conventional products and keep their employees safe. But 2020 astounded expectations, with some vaccine candidates developed over a matter of weeks. Given the rapid pace of the vaccine research and development, Uwe Gottschalk asked, “how can we apply it, learn from it and implement it elsewhere?”

Once vaccines are developed, however, hundreds of millions of doses must be produced. To accelerate production, companies are taking advantage of innovations such as virtual reality training of specialists and artificial intelligence enhanced processes. Manufacturing can be expanded by making use of multiple facilities. But not all innovation comes from development and production. Careful consideration of who to vaccinate with which vaccine can have profound impacts on the course of the pandemic.

Carlos Guzmán

Helmholtz Centre for Infection Research

Prof. Carlos A. Guzmán (MD, PhD) is Head of the Department Vaccinology and Applied Microbiology at the Helmholtz Centre for Infection Research and also APL professor at the Hannover Medical School.

He studied Medicine at the National University of Rosario and received his specialization in Medical Bacteriology in Argentina. With a scholarship from the Italian Foreign Ministry, he then conducted research at the Institute of Microbiology at the University of Genoa, Italy. He acquired his doctorate in Medicine and Surgery, becoming also a doctor in Microbiological Sciences.

In 1994, he moved to Germany and became head of the Vaccine Research group at the HZI, formerly GBF. He has been active in the field of Vaccinology since 1989. His work led to the discovery of new adjuvants, the establishment of Salmonella spp. as a delivery system for DNA vaccines and therapeutic molecules, and the development of vaccine candidates against different infectious diseases. He has published over 260 papers in international journals and is co-inventor of numerous international patents.

Prof. Guzmán is part of the editorial board of Microbial Biotechnology, Bioengineered and Microbial Immunology. He is also review editor of Frontiers in Mucosal Immunology, as well as member of “Council of 100”of Vaccine. In addition he is speaker of the topic “Immune Response and Intervention” of the program “Infection Research” of the Helmholtz Association.

Leave a comment

Log in to Comment
Further Activities to have a look at

We use cookies and other technologies to collect data about your use of our site and about your browser, device and location. We process this data to help us understand how the site is used and to personalize our content and the advertising you see on this and other sites we also share this data with advertising, social media and analytics partners for the same purposes. By choosing “Accept All” you agree that we store cookies on your device and process the data for the aforementioned purposes . You may revoke your consent at any time by choosing the respective settings. For more information on the processing of personal data and what specific services we use see our Privacy Policy

Privacy Preference Center

We use cookies and other technologies to collect data about your use of our site and about your browser, device and location. We process this data to help us understand how the site is used and to personalize our content and the advertising you see on this and other sites we also share this data with advertising, social media and analytics partners for the same purposes. By choosing “Accept All” you agree that we store cookies on your device and process the data for the aforementioned purposes . You may revoke your consent at any time by choosing the respective settings. For more information on the processing of personal data and what specific services we use see our Privacy Policy

Necessary Cookies

These cookies are required to provide you with our site and its functions. Since storing these cookies is necessary for the provision of our site and its functions, you cannot disable them. If you block these cookies via you browser settings our site may not function properly.

Analyse Cookies

These cookies enable us to use website analytics in order to improve our site or provide you with personalized content. They may be set by us or by third party providers whose services we have added to our pages.

Marketing Cookies

These cookies enable us to use online marketing and advertising in order to provide you on this or on other sites with personalized advertisement. They may be set by us or by third party providers whose services we have added to our pages.